Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: A randomized controlled trial

• Main Authors: Weerachai Srivanichakorn, Apiradee Sriwijitkamol, Aroon Kongchoo, Sutin Sriussadaporn, Nattachet Plengvidhya, R. Aweewan Lertwattanarak, Sathit Vannasaeng, Nuntakorn Thongtang
• Other Authors: Mahidol University
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/36497

© 2015 Srivanichakorn et al. Background: The benefit of sulfonylureas (SUs) to patients with type 2 diabetes mellitus receiving long-term insulin treatment is unclear. This study evaluated glycemic control and beta-cell function after SU withdrawal in these patients. Methods: In this 8-week randomiz...